According to this study, over the next five years the Influenza Virus Vaccine (H1N1) market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Influenza Virus Vaccine (H1N1) business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Influenza Virus Vaccine (H1N1) market by type, application, key manufacturers and key regions and countries.
This study considers the Influenza Virus Vaccine (H1N1) value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
- Intramuscular Vaccine
- Nasal Spray Vaccine
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
- 3 To 10 Years Old
- 10 To 18 Years Old
- Above 18 Years Old
- Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
- CSL
- Beijing Tiantan Bio-Products
- NVS(Novartis)
- Medimmune
- GSK
- Sanofi Pasteur
- Hualan Bio-Vaccine
- Baxter
- Changchun Changsheng Bio-Technology
- Beijing Kexing Bio-Vaccine
- Jiangsu Yanshen Bio-Technology
- Sinopharm
- Dalian Yalifeng Bio-Pharmaceutical
- Zhejiang Tianyuan Bio-Pharmaceutical
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
- To study and analyze the global Influenza Virus Vaccine (H1N1) consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
- To understand the structure of Influenza Virus Vaccine (H1N1) market by identifying its various subsegments.
- Focuses on the key global Influenza Virus Vaccine (H1N1) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the Influenza Virus Vaccine (H1N1) with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the consumption of Influenza Virus Vaccine (H1N1) submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
Global Influenza Virus Vaccine (H1N1) Market Growth 2020-2025
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Influenza Virus Vaccine (H1N1) Consumption 2015-2025
2.1.2 Influenza Virus Vaccine (H1N1) Consumption CAGR by Region
2.2 Influenza Virus Vaccine (H1N1) Segment by Type
2.2.1 Intramuscular Vaccine
2.2.2 Nasal Spray Vaccine
2.3 Influenza Virus Vaccine (H1N1) Consumption by Type
2.3.1 Global Influenza Virus Vaccine (H1N1) Consumption Market Share by Type (2015-2020)
2.3.2 Global Influenza Virus Vaccine (H1N1) Revenue and Market Share by Type (2015-2020)
2.3.3 Global Influenza Virus Vaccine (H1N1) Sale Price by Type (2015-2020)
2.4 Influenza Virus Vaccine (H1N1) Segment by Application
2.4.1 3 To 10 Years Old
2.4.2 10 To 18 Years Old
2.4.3 Above 18 Years Old
2.4.4 Other
2.5 Influenza Virus Vaccine (H1N1) Consumption by Application
2.5.1 Global Influenza Virus Vaccine (H1N1) Consumption Market Share by Type (2015-2020)
2.5.2 Global Influenza Virus Vaccine (H1N1) Value and Market Share by Type (2015-2020)
2.5.3 Global Influenza Virus Vaccine (H1N1) Sale Price by Type (2015-2020)
3 Global Influenza Virus Vaccine (H1N1) by Company
3.1 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Company
3.1.1 Global Influenza Virus Vaccine (H1N1) Sales by Company (2018-2020)
3.1.2 Global Influenza Virus Vaccine (H1N1) Sales Market Share by Company (2018-2020)
3.2 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Company
3.2.1 Global Influenza Virus Vaccine (H1N1) Revenue by Company (2018-2020)
3.2.2 Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Company (2018-2020)
3.3 Global Influenza Virus Vaccine (H1N1) Sale Price by Company
3.4 Global Influenza Virus Vaccine (H1N1) Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Influenza Virus Vaccine (H1N1) Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Influenza Virus Vaccine (H1N1) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Influenza Virus Vaccine (H1N1) by Regions
4.1 Influenza Virus Vaccine (H1N1) by Regions
4.2 Americas Influenza Virus Vaccine (H1N1) Consumption Growth
4.3 APAC Influenza Virus Vaccine (H1N1) Consumption Growth
4.4 Europe Influenza Virus Vaccine (H1N1) Consumption Growth
4.5 Middle East & Africa Influenza Virus Vaccine (H1N1) Consumption Growth
5 Americas
5.1 Americas Influenza Virus Vaccine (H1N1) Consumption by Countries
5.1.1 Americas Influenza Virus Vaccine (H1N1) Consumption by Countries (2015-2020)
5.1.2 Americas Influenza Virus Vaccine (H1N1) Value by Countries (2015-2020)
5.2 Americas Influenza Virus Vaccine (H1N1) Consumption by Type
5.3 Americas Influenza Virus Vaccine (H1N1) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Influenza Virus Vaccine (H1N1) Consumption by Regions
6.1.1 APAC Influenza Virus Vaccine (H1N1) Consumption by Regions (2015-2020)
6.1.2 APAC Influenza Virus Vaccine (H1N1) Value by Regions (2015-2020)
6.2 APAC Influenza Virus Vaccine (H1N1) Consumption by Type
6.3 APAC Influenza Virus Vaccine (H1N1) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Influenza Virus Vaccine (H1N1) by Countries
7.1.1 Europe Influenza Virus Vaccine (H1N1) Consumption by Countries (2015-2020)
7.1.2 Europe Influenza Virus Vaccine (H1N1) Value by Countries (2015-2020)
7.2 Europe Influenza Virus Vaccine (H1N1) Consumption by Type
7.3 Europe Influenza Virus Vaccine (H1N1) Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Influenza Virus Vaccine (H1N1) by Countries
8.1.1 Middle East & Africa Influenza Virus Vaccine (H1N1) Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Influenza Virus Vaccine (H1N1) Value by Countries (2015-2020)
8.2 Middle East & Africa Influenza Virus Vaccine (H1N1) Consumption by Type
8.3 Middle East & Africa Influenza Virus Vaccine (H1N1) Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Influenza Virus Vaccine (H1N1) Distributors
10.3 Influenza Virus Vaccine (H1N1) Customer
11 Global Influenza Virus Vaccine (H1N1) Market Forecast
11.1 Global Influenza Virus Vaccine (H1N1) Consumption Forecast (2021-2025)
11.2 Global Influenza Virus Vaccine (H1N1) Forecast by Regions
11.2.1 Global Influenza Virus Vaccine (H1N1) Forecast by Regions (2021-2025)
11.2.2 Global Influenza Virus Vaccine (H1N1) Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Influenza Virus Vaccine (H1N1) Forecast by Type
11.8 Global Influenza Virus Vaccine (H1N1) Forecast by Application
12 Key Players Analysis
12.1 CSL
12.1.1 Company Information
12.1.2 Influenza Virus Vaccine (H1N1) Product Offered
12.1.3 CSL Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 CSL Latest Developments
12.2 Beijing Tiantan Bio-Products
12.2.1 Company Information
12.2.2 Influenza Virus Vaccine (H1N1) Product Offered
12.2.3 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Beijing Tiantan Bio-Products Latest Developments
12.3 NVS(Novartis)
12.3.1 Company Information
12.3.2 Influenza Virus Vaccine (H1N1) Product Offered
12.3.3 NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 NVS(Novartis) Latest Developments
12.4 Medimmune
12.4.1 Company Information
12.4.2 Influenza Virus Vaccine (H1N1) Product Offered
12.4.3 Medimmune Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Medimmune Latest Developments
12.5 GSK
12.5.1 Company Information
12.5.2 Influenza Virus Vaccine (H1N1) Product Offered
12.5.3 GSK Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 GSK Latest Developments
12.6 Sanofi Pasteur
12.6.1 Company Information
12.6.2 Influenza Virus Vaccine (H1N1) Product Offered
12.6.3 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Sanofi Pasteur Latest Developments
12.7 Hualan Bio-Vaccine
12.7.1 Company Information
12.7.2 Influenza Virus Vaccine (H1N1) Product Offered
12.7.3 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Hualan Bio-Vaccine Latest Developments
12.8 Baxter
12.8.1 Company Information
12.8.2 Influenza Virus Vaccine (H1N1) Product Offered
12.8.3 Baxter Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Baxter Latest Developments
12.9 Changchun Changsheng Bio-Technology
12.9.1 Company Information
12.9.2 Influenza Virus Vaccine (H1N1) Product Offered
12.9.3 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Changchun Changsheng Bio-Technology Latest Developments
12.10 Beijing Kexing Bio-Vaccine
12.10.1 Company Information
12.10.2 Influenza Virus Vaccine (H1N1) Product Offered
12.10.3 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Beijing Kexing Bio-Vaccine Latest Developments
12.11 Jiangsu Yanshen Bio-Technology
12.11.1 Company Information
12.11.2 Influenza Virus Vaccine (H1N1) Product Offered
12.11.3 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Jiangsu Yanshen Bio-Technology Latest Developments
12.12 Sinopharm
12.12.1 Company Information
12.12.2 Influenza Virus Vaccine (H1N1) Product Offered
12.12.3 Sinopharm Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Sinopharm Latest Developments
12.13 Dalian Yalifeng Bio-Pharmaceutical
12.13.1 Company Information
12.13.2 Influenza Virus Vaccine (H1N1) Product Offered
12.13.3 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Dalian Yalifeng Bio-Pharmaceutical Latest Developments
12.14 Zhejiang Tianyuan Bio-Pharmaceutical
12.14.1 Company Information
12.14.2 Influenza Virus Vaccine (H1N1) Product Offered
12.14.3 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Zhejiang Tianyuan Bio-Pharmaceutical Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Influenza Virus Vaccine (H1N1) Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Intramuscular Vaccine
Table 5. Major Players of Nasal Spray Vaccine
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Influenza Virus Vaccine (H1N1) Consumption Market Share by Type (2015-2020)
Table 8. Global Influenza Virus Vaccine (H1N1) Revenue by Type (2015-2020) ($ million)
Table 9. Global Influenza Virus Vaccine (H1N1) Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Influenza Virus Vaccine (H1N1) Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Influenza Virus Vaccine (H1N1) Consumption Market Share by Application (2015-2020)
Table 13. Global Influenza Virus Vaccine (H1N1) Value by Application (2015-2020)
Table 14. Global Influenza Virus Vaccine (H1N1) Value Market Share by Application (2015-2020)
Table 15. Global Influenza Virus Vaccine (H1N1) Sale Price by Application (2015-2020)
Table 16. Global Influenza Virus Vaccine (H1N1) Sales by Company (2017-2019) (K Doses)
Table 17. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Company (2017-2019)
Table 18. Global Influenza Virus Vaccine (H1N1) Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Company (2017-2019)
Table 20. Global Influenza Virus Vaccine (H1N1) Sale Price by Company (2017-2019)
Table 21. Global Influenza Virus Vaccine (H1N1) Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Influenza Virus Vaccine (H1N1) Products Offered
Table 23. Influenza Virus Vaccine (H1N1) Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Influenza Virus Vaccine (H1N1) Consumption by Regions 2015-2020 (K Doses)
Table 25. Global Influenza Virus Vaccine (H1N1) Consumption Market Share by Regions 2015-2020
Table 26. Global Influenza Virus Vaccine (H1N1) Value by Regions 2015-2020 ($ Millions)
Table 27. Global Influenza Virus Vaccine (H1N1) Value Market Share by Regions 2015-2020
Table 28. Americas Influenza Virus Vaccine (H1N1) Consumption by Countries (2015-2020) (K Doses)
Table 29. Americas Influenza Virus Vaccine (H1N1) Consumption Market Share by Countries (2015-2020)
Table 30. Americas Influenza Virus Vaccine (H1N1) Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Influenza Virus Vaccine (H1N1) Value Market Share by Countries (2015-2020)
Table 32. Americas Influenza Virus Vaccine (H1N1) Consumption by Type (2015-2020) (K Doses)
Table 33. Americas Influenza Virus Vaccine (H1N1) Consumption Market Share by Type (2015-2020)
Table 34. Americas Influenza Virus Vaccine (H1N1) Consumption by Application (2015-2020) (K Doses)
Table 35. Americas Influenza Virus Vaccine (H1N1) Consumption Market Share by Application (2015-2020)
Table 36. APAC Influenza Virus Vaccine (H1N1) Consumption by Countries (2015-2020) (K Doses)
Table 37. APAC Influenza Virus Vaccine (H1N1) Consumption Market Share by Countries (2015-2020)
Table 38. APAC Influenza Virus Vaccine (H1N1) Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Influenza Virus Vaccine (H1N1) Value Market Share by Regions (2015-2020)
Table 40. APAC Influenza Virus Vaccine (H1N1) Consumption by Type (2015-2020) (K Doses)
Table 41. APAC Influenza Virus Vaccine (H1N1) Consumption Market Share by Type (2015-2020)
Table 42. APAC Influenza Virus Vaccine (H1N1) Consumption by Application (2015-2020) (K Doses)
Table 43. APAC Influenza Virus Vaccine (H1N1) Consumption Market Share by Application (2015-2020)
Table 44. Europe Influenza Virus Vaccine (H1N1) Consumption by Countries (2015-2020) (K Doses)
Table 45. Europe Influenza Virus Vaccine (H1N1) Consumption Market Share by Countries (2015-2020)
Table 46. Europe Influenza Virus Vaccine (H1N1) Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Influenza Virus Vaccine (H1N1) Value Market Share by Countries (2015-2020)
Table 48. Europe Influenza Virus Vaccine (H1N1) Consumption by Type (2015-2020) (K Doses)
Table 49. Europe Influenza Virus Vaccine (H1N1) Consumption Market Share by Type (2015-2020)
Table 50. Europe Influenza Virus Vaccine (H1N1) Consumption by Application (2015-2020) (K Doses)
Table 51. Europe Influenza Virus Vaccine (H1N1) Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Influenza Virus Vaccine (H1N1) Consumption by Countries (2015-2020) (K Doses)
Table 53. Middle East & Africa Influenza Virus Vaccine (H1N1) Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Influenza Virus Vaccine (H1N1) Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Influenza Virus Vaccine (H1N1) Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Influenza Virus Vaccine (H1N1) Consumption by Type (2015-2020) (K Doses)
Table 57. Middle East & Africa Influenza Virus Vaccine (H1N1) Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Influenza Virus Vaccine (H1N1) Consumption by Application (2015-2020) (K Doses)
Table 59. Middle East & Africa Influenza Virus Vaccine (H1N1) Consumption Market Share by Application (2015-2020)
Table 60. Influenza Virus Vaccine (H1N1) Distributors List
Table 61. Influenza Virus Vaccine (H1N1) Customer List
Table 62. Global Influenza Virus Vaccine (H1N1) Consumption Forecast by Countries (2021-2025) (K Doses)
Table 63. Global Influenza Virus Vaccine (H1N1) Consumption Market Forecast by Regions
Table 64. Global Influenza Virus Vaccine (H1N1) Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Influenza Virus Vaccine (H1N1) Value Market Share Forecast by Regions
Table 66. Global Influenza Virus Vaccine (H1N1) Consumption Forecast by Type (2021-2025) (K Doses)
Table 67. Global Influenza Virus Vaccine (H1N1) Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Influenza Virus Vaccine (H1N1) Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Influenza Virus Vaccine (H1N1) Value Market Share Forecast by Type (2021-2025)
Table 70. Global Influenza Virus Vaccine (H1N1) Consumption Forecast by Application (2021-2025) (K Doses)
Table 71. Global Influenza Virus Vaccine (H1N1) Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Influenza Virus Vaccine (H1N1) Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Influenza Virus Vaccine (H1N1) Value Market Share Forecast by Application (2021-2025)
Table 74. CSL Product Offered
Table 75. CSL Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 76. CSL Main Business
Table 77. CSL Latest Developments
Table 78. CSL Basic Information, Company Total Revenue (in $ million), Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 79. Beijing Tiantan Bio-Products Product Offered
Table 80. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 81. Beijing Tiantan Bio-Products Main Business
Table 82. Beijing Tiantan Bio-Products Latest Developments
Table 83. Beijing Tiantan Bio-Products Basic Information, Company Total Revenue (in $ million), Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 84. NVS(Novartis) Product Offered
Table 85. NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 86. NVS(Novartis) Main Business
Table 87. NVS(Novartis) Latest Developments
Table 88. NVS(Novartis) Basic Information, Company Total Revenue (in $ million), Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 89. Medimmune Product Offered
Table 90. Medimmune Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 91. Medimmune Main Business
Table 92. Medimmune Latest Developments
Table 93. Medimmune Basic Information, Company Total Revenue (in $ million), Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 94. GSK Product Offered
Table 95. GSK Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 96. GSK Main Business
Table 97. GSK Latest Developments
Table 98. GSK Basic Information, Company Total Revenue (in $ million), Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 99. Sanofi Pasteur Product Offered
Table 100. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 101. Sanofi Pasteur Main Business
Table 102. Sanofi Pasteur Latest Developments
Table 103. Sanofi Pasteur Basic Information, Company Total Revenue (in $ million), Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 104. Hualan Bio-Vaccine Product Offered
Table 105. Hualan Bio-Vaccine Basic Information, Company Total Revenue (in $ million), Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 106. Hualan Bio-Vaccine Main Business
Table 107. Hualan Bio-Vaccine Latest Developments
Table 108. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 109. Baxter Product Offered
Table 110. Baxter Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 111. Baxter Main Business
Table 112. Baxter Latest Developments
Table 113. Baxter Basic Information, Company Total Revenue (in $ million), Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 114. Changchun Changsheng Bio-Technology Product Offered
Table 115. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 116. Changchun Changsheng Bio-Technology Main Business
Table 117. Changchun Changsheng Bio-Technology Latest Developments
Table 118. Changchun Changsheng Bio-Technology Basic Information, Company Total Revenue (in $ million), Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 119. Beijing Kexing Bio-Vaccine Product Offered
Table 120. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 121. Beijing Kexing Bio-Vaccine Main Business
Table 122. Beijing Kexing Bio-Vaccine Latest Developments
Table 123. Beijing Kexing Bio-Vaccine Basic Information, Company Total Revenue (in $ million), Influenza Virus Vaccine (H1N1) Manufacturing Base, Sales Area and Its Competitors
Table 124. Jiangsu Yanshen Bio-Technology Product Offered
Table 125. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 126. Jiangsu Yanshen Bio-Technology Main Business
Table 127. Jiangsu Yanshen Bio-Technology Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. Jiangsu Yanshen Bio-Technology Latest Developments
Table 129. Sinopharm Product Offered
Table 130. Sinopharm Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 131. Sinopharm Main Business
Table 132. Sinopharm Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. Sinopharm Latest Developments
Table 134. Dalian Yalifeng Bio-Pharmaceutical Product Offered
Table 135. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 136. Dalian Yalifeng Bio-Pharmaceutical Main Business
Table 137. Dalian Yalifeng Bio-Pharmaceutical Latest Developments
Table 138. Dalian Yalifeng Bio-Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 139. Zhejiang Tianyuan Bio-Pharmaceutical Product Offered
Table 140. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 141. Zhejiang Tianyuan Bio-Pharmaceutical Main Business
Table 142. Zhejiang Tianyuan Bio-Pharmaceutical Latest Developments
Table 143. Zhejiang Tianyuan Bio-Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Influenza Virus Vaccine (H1N1)
Figure 2. Influenza Virus Vaccine (H1N1) Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Influenza Virus Vaccine (H1N1) Consumption Growth Rate 2015-2025 (K Doses)
Figure 5. Global Influenza Virus Vaccine (H1N1) Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Intramuscular Vaccine
Figure 7. Product Picture of Nasal Spray Vaccine
Figure 8. Global Influenza Virus Vaccine (H1N1) Consumption Market Share by Type (2015-2020)
Figure 9. Global Influenza Virus Vaccine (H1N1) Value Market Share by Type (2015-2020)
Figure 10. Influenza Virus Vaccine (H1N1) Consumed in 3 To 10 Years Old
Figure 11. Global Influenza Virus Vaccine (H1N1) Market: 3 To 10 Years Old (2015-2020) (K Doses)
Figure 12. Global Influenza Virus Vaccine (H1N1) Market: 3 To 10 Years Old (2015-2020) ($ Millions)
Figure 13. Influenza Virus Vaccine (H1N1) Consumed in 10 To 18 Years Old
Figure 14. Global Influenza Virus Vaccine (H1N1) Market: 10 To 18 Years Old (2015-2020) (K Doses)
Figure 15. Global Influenza Virus Vaccine (H1N1) Market: 10 To 18 Years Old (2015-2020) ($ Millions)
Figure 16. Influenza Virus Vaccine (H1N1) Consumed in Above 18 Years Old
Figure 17. Global Influenza Virus Vaccine (H1N1) Market: Above 18 Years Old (2015-2020) (K Doses)
Figure 18. Global Influenza Virus Vaccine (H1N1) Market: Above 18 Years Old (2015-2020) ($ Millions)
Figure 19. Influenza Virus Vaccine (H1N1) Consumed in Other
Figure 20. Global Influenza Virus Vaccine (H1N1) Market: Other (2015-2020) (K Doses)
Figure 21. Global Influenza Virus Vaccine (H1N1) Market: Other (2015-2020) ($ Millions)
Figure 22. Global Influenza Virus Vaccine (H1N1) Consumption Market Share by Application (2015-2020)
Figure 23. Global Influenza Virus Vaccine (H1N1) Value Market Share by Application (2015-2020)
Figure 24. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Company in 2017
Figure 25. Global Influenza Virus Vaccine (H1N1) Sales Market Share by Company in 2019
Figure 26. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Company in 2017
Figure 27. Global Influenza Virus Vaccine (H1N1) Revenue Market Share by Company in 2019
Figure 28. Global Influenza Virus Vaccine (H1N1) Sale Price by Company in 2019
Figure 29. Global Influenza Virus Vaccine (H1N1) Consumption Market Share by Regions 2015-2020
Figure 30. Global Influenza Virus Vaccine (H1N1) Value Market Share by Regions 2015-2020
Figure 31. Americas Influenza Virus Vaccine (H1N1) Consumption 2015-2020 (K Doses)
Figure 32. Americas Influenza Virus Vaccine (H1N1) Value 2015-2020 ($ Millions)
Figure 33. APAC Influenza Virus Vaccine (H1N1) Consumption 2015-2020 (K Doses)
Figure 34. APAC Influenza Virus Vaccine (H1N1) Value 2015-2020 ($ Millions)
Figure 35. Europe Influenza Virus Vaccine (H1N1) Consumption 2015-2020 (K Doses)
Figure 36. Europe Influenza Virus Vaccine (H1N1) Value 2015-2020 ($ Millions)
Figure 37. Middle East & Africa Influenza Virus Vaccine (H1N1) Consumption 2015-2020 (K Doses)
Figure 38. Middle East & Africa Influenza Virus Vaccine (H1N1) Value 2015-2020 ($ Millions)
Figure 39. Americas Influenza Virus Vaccine (H1N1) Consumption Market Share by Countries in 2019
Figure 40. Americas Influenza Virus Vaccine (H1N1) Value Market Share by Countries in 2019
Figure 41. Americas Influenza Virus Vaccine (H1N1) Consumption Market Share by Type in 2019
Figure 42. Americas Influenza Virus Vaccine (H1N1) Consumption Market Share by Application in 2019
Figure 43. United States Influenza Virus Vaccine (H1N1) Consumption Growth 2015-2020 (K Doses)
Figure 44. United States Influenza Virus Vaccine (H1N1) Value Growth 2015-2020 ($ Millions)
Figure 45. Canada Influenza Virus Vaccine (H1N1) Consumption Growth 2015-2020 (K Doses)
Figure 46. Canada Influenza Virus Vaccine (H1N1) Value Growth 2015-2020 ($ Millions)
Figure 47. Mexico Influenza Virus Vaccine (H1N1) Consumption Growth 2015-2020 (K Doses)
Figure 48. Mexico Influenza Virus Vaccine (H1N1) Value Growth 2015-2020 ($ Millions)
Figure 49. APAC Influenza Virus Vaccine (H1N1) Consumption Market Share by Countries in 2019
Figure 50. APAC Influenza Virus Vaccine (H1N1) Value Market Share by Regions in 2019
Figure 51. APAC Influenza Virus Vaccine (H1N1) Consumption Market Share by Type in 2019
Figure 52. APAC Influenza Virus Vaccine (H1N1) Consumption Market Share by Application in 2019
Figure 53. China Influenza Virus Vaccine (H1N1) Consumption Growth 2015-2020 (K Doses)
Figure 54. China Influenza Virus Vaccine (H1N1) Value Growth 2015-2020 ($ Millions)
Figure 55. Japan Influenza Virus Vaccine (H1N1) Consumption Growth 2015-2020 (K Doses)
Figure 56. Japan Influenza Virus Vaccine (H1N1) Value Growth 2015-2020 ($ Millions)
Figure 57. Korea Influenza Virus Vaccine (H1N1) Consumption Growth 2015-2020 (K Doses)
Figure 58. Korea Influenza Virus Vaccine (H1N1) Value Growth 2015-2020 ($ Millions)
Figure 59. Southeast Asia Influenza Virus Vaccine (H1N1) Consumption Growth 2015-2020 (K Doses)
Figure 60. Southeast Asia Influenza Virus Vaccine (H1N1) Value Growth 2015-2020 ($ Millions)
Figure 61. India Influenza Virus Vaccine (H1N1) Consumption Growth 2015-2020 (K Doses)
Figure 62. India Influenza Virus Vaccine (H1N1) Value Growth 2015-2020 ($ Millions)
Figure 63. Australia Influenza Virus Vaccine (H1N1) Consumption Growth 2015-2020 (K Doses)
Figure 64. Australia Influenza Virus Vaccine (H1N1) Value Growth 2015-2020 ($ Millions)
Figure 65. Europe Influenza Virus Vaccine (H1N1) Consumption Market Share by Countries in 2019
Figure 66. Europe Influenza Virus Vaccine (H1N1) Value Market Share by Countries in 2019
Figure 67. Europe Influenza Virus Vaccine (H1N1) Consumption Market Share by Type in 2019
Figure 68. Europe Influenza Virus Vaccine (H1N1) Consumption Market Share by Application in 2019
Figure 69. Germany Influenza Virus Vaccine (H1N1) Consumption Growth 2015-2020 (K Doses)
Figure 70. Germany Influenza Virus Vaccine (H1N1) Value Growth 2015-2020 ($ Millions)
Figure 71. France Influenza Virus Vaccine (H1N1) Consumption Growth 2015-2020 (K Doses)
Figure 72. France Influenza Virus Vaccine (H1N1) Value Growth 2015-2020 ($ Millions)
Figure 73. UK Influenza Virus Vaccine (H1N1) Consumption Growth 2015-2020 (K Doses)
Figure 74. UK Influenza Virus Vaccine (H1N1) Value Growth 2015-2020 ($ Millions)
Figure 75. Italy Influenza Virus Vaccine (H1N1) Consumption Growth 2015-2020 (K Doses)
Figure 76. Italy Influenza Virus Vaccine (H1N1) Value Growth 2015-2020 ($ Millions)
Figure 77. Russia Influenza Virus Vaccine (H1N1) Consumption Growth 2015-2020 (K Doses)
Figure 78. Russia Influenza Virus Vaccine (H1N1) Value Growth 2015-2020 ($ Millions)
Figure 79. Middle East
Global Antioxidant Vitamins Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 100
The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
Global Clavulanate Potassium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030.
North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
Global Amoxicillin Sodium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 84
The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030.
North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
Global Melatonin Supplements Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 93
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
Global Sleeping Pills Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Zinc Oral Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
Global Zinc Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
Global Anti-Infectives Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
